Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 06-1999 | |
| Gross Profit | N/A | N/A | N/A | N/A | 20,170 |
| Operating Expenses | 5,734 | 0 | 3,076 | 3,227 | 0 |
| Operating Income | -5,734 | N/A | -3,076 | -3,227 | N/A |
| Other Income | -10 | 0 | 29 | 93 | 0 |
| Pre-tax Income | -5,744 | 0 | -3,047 | -3,134 | 0 |
| Income Tax | 40 | N/A | N/A | 58 | N/A |
| Net Income Continuous | -5,784 | N/A | -3,047 | -3,192 | -50 |
| Net Income | $-5,784 | $N/A | $-3,047 | $-3,192 | $-50 |
| EPS Basic Total Ops | -0.10 | N/A | -0.06 | -0.07 | N/A |
| EPS Basic Continuous Ops | -0.10 | N/A | -0.06 | -0.07 | N/A |
| EPS Diluted Total Ops | -0.10 | N/A | -0.06 | -0.07 | N/A |
| EPS Diluted Continuous Ops | -0.10 | N/A | -0.06 | -0.07 | N/A |
| EBITDA(a) | $-5,731 | $N/A | $-3,076 | $-3,227 | $2,890 |